No Data
Piper Sandler Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $48
10 Health Care Stocks With Whale Alerts In Today's Session
H.C. Wainwright Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $40
Express News | HC Wainwright & Co. Maintains Buy on Avalo Therapeutics, Raises Price Target to $40
Mizuho Securities Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $39
Wedbush Raises Price Target on Avalo Therapeutics to $29 From $28, Keeps Outperform Rating